Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 11, Issue 1, Pages 19-22Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2010.09.020
Keywords
Toll-like receptor 4; Lipopolysaccharide; Dimerization; Interferon regulatory factor 3; Fumaryl oxazolidinone
Categories
Funding
- Ministry of Environment of the Republic of Korea
- Ministry of Education, Science & Tehnology (MEST)
- National Research Foundation of Korea (NRF)
Ask authors/readers for more resources
Toll-like receptors (TLRs) recognize molecular structures derived from microbes and initiate innate immunity. The stimulation of TLR4 by lipopolysaccharide (LPS) triggers the activation of the myeloid differential factor 88 (MyD88)-dependent and toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent major downstream signaling pathways. Previously, we synthesized a fumaryl oxazolidinone derivative, 4-oxo-4-(2-oxo-oxazolidin-3-yl)-but-2-enoic acid ethyl ester (OSL07) and demonstrated that it inhibits activation of nuclear factor kappa B (NF-kappa B) by inhibiting the MyD88-dependent pathway of TLRs. TLR4 and the downstream signaling components are good therapeutic targets for many chronic inflammatory diseases. Here, it is investigated whether OSL07 modulates TLR4 downstream signaling pathways and what anti-inflammatory target in TLR4 signaling is regulated by OSL07. OSL07 inhibited LPS-induced NF-kappa B and interferon regulatory factor 3 activation by targeting TLR4 dimerization. These results suggest that OSL07 can modulate TLR4 signaling pathway leading to decreased inflammatory gene expression. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available